76 related articles for article (PubMed ID: 7871286)
1. [Is there value in determining tumor markers in senology?].
Van Cauwenberge JR; Collette J; Franchimont P
Rev Med Liege; 1995 Jan; 50(1):41-5. PubMed ID: 7871286
[No Abstract] [Full Text] [Related]
2. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
Surg Forum; 1978; 29():162-4. PubMed ID: 401123
[TBL] [Abstract][Full Text] [Related]
3. Immunoperoxidase staining for tumor markers in patients with carcinoma of the breast.
Cox CE; Haagensen DE; Dilley WG; Wells SA
Surg Forum; 1978; 29():160-2. PubMed ID: 401405
[No Abstract] [Full Text] [Related]
4. Tumor markers for breast carcinoma.
Haagensen DE
Clin Lab Med; 1982 Sep; 2(3):543-65. PubMed ID: 6754225
[No Abstract] [Full Text] [Related]
5. Breast cancer metastatic to the eyelids.
Claessens N; Rakic L; Arrese JE; Pierard GE
Eur J Dermatol; 2000 Aug; 10(6):473-4. PubMed ID: 10980473
[TBL] [Abstract][Full Text] [Related]
6. Tumor associated markers in breast cancer.
Franchimont P; Zangerle PF; Colin C; Osterrieth P; Hendrick JC; van Cauwenberge JR; Hustin J
Eur J Cancer (1965); 1980; Suppl 1():17-20. PubMed ID: 6172278
[No Abstract] [Full Text] [Related]
7. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
[TBL] [Abstract][Full Text] [Related]
8. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
Fornelli A; Bacci A; Collina G; Eusebi V
Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
[TBL] [Abstract][Full Text] [Related]
9. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
[TBL] [Abstract][Full Text] [Related]
10. The biochemistry of cyst fluids.
Miller WR
Br J Clin Pract Suppl; 1989 Nov; 68():94-9; discussion 111-5. PubMed ID: 2488573
[No Abstract] [Full Text] [Related]
11. Tamoxifen in breast cancer.
Anand A
Hosp Pract (Off Ed); 1993 Jun; 28(6):17. PubMed ID: 8509477
[No Abstract] [Full Text] [Related]
12. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
Rodríguez CA; Cruz JJ; Martín T; Gómez A; Olaverri A; Hernández M
Cancer; 2002 Aug; 95(3):670-1; author reply 671. PubMed ID: 12209762
[No Abstract] [Full Text] [Related]
13. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
14. Review of GCDFP-15. An apocrine marker protein.
Haagensen DE; Dilley WG; Mazoujian G; Wells SA
Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
[No Abstract] [Full Text] [Related]
15. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma.
Dilley WG; Leight GS; Silva JS; Ammirata S; Haagensen DE; Wells SA
J Natl Cancer Inst; 1983 Jan; 70(1):69-74. PubMed ID: 6571924
[TBL] [Abstract][Full Text] [Related]
16. Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.
Heinze T; Schürenkämper P; Minguillon C; Lichtenegger W
Anticancer Res; 1997; 17(4B):2953-4. PubMed ID: 9329573
[TBL] [Abstract][Full Text] [Related]
17. Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.
Sapino A; Cassoni P; Bussolati G
J Biol Regul Homeost Agents; 2000; 14(4):259-62. PubMed ID: 11215813
[No Abstract] [Full Text] [Related]
18. Morphofunctional findings in adenocarcinoma of endometrium.
Eusebi V; Pelusi G; Bondi A; Morichelli MP; Ceccarelli C; Cavallina R; Mancini AM
Tumori; 1984 Jun; 70(3):291-5. PubMed ID: 6204431
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast carcinoma presenting as endometrial cancer. A case report.
Lallas TA; Taskin M; Calanog A; Shevchuk MM
J Reprod Med; 1997 Feb; 42(2):121-3. PubMed ID: 9058349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
